Von dem Buch Gene therapy : principles and applications. ed. by haben wir 4 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Blankenstein, Thomas: Gene therapy : principles and applications. ed. by (ISBN: 9783764359720) Erstausgabe, in Englisch, Broschiert.Nur diese Ausgabe anzeigen…
61%: Editor: Thomas Blankenstein: Gene Therapy: Principles and Applications (ISBN: 9780817659721) Birkhauser Verlag, in Englisch, Broschiert.Nur diese Ausgabe anzeigen…
50%: Blankenstein (Herausgeber): Gene Therapy: Principles and Applications Editor (ISBN: 9783034870139) 2012, Birkhäuser Basel; Springer Basel, in Englisch, Taschenbuch.Nur diese Ausgabe anzeigen…
40%: Hugo S. L. Hens: Gene Therapy : Principles and Applications (ISBN: 9783034870115) in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
Gene therapy : principles and applications. ed. by - 18 Angebote vergleichen
| Preise | 2013 | 2014 | 2015 | 2017 | 2020 |
|---|---|---|---|---|---|
| Schnitt | € 56,65 | € 63,06 | € 61,49 | € 66,18 | € 63,16 |
| Nachfrage |
1
Gene Therapy
~EN PB NWISBN: 9783034870139 bzw. 3034870132, vermutlich in Englisch, Springer Shop, Taschenbuch, neu.
Lieferung aus: Deutschland, Lagernd.
K. Sikora Gene therapy is one of the fastest developing areas in modern medical research. Transcending the classical preclinical and clinical disciplines, it is likely to have far reaching consequences in the practice of medicine, as we enter the next millennium. Currently, there are over 200 seperate active clinical trials with over 2,500 patients entered. These studies involve over 20 countries and include patients with a wide range of diseases, including cancer, HIV infection; cystic fibrosis (CF), haemophilia, diabetes, immune deficiencies, metabolic disorders, ischaemic heart disease and arthritis. Gene therapy can be defined as the deliberate transfer of DNA for therapeutic purposes. There is a further implication that only specific sequences containing rel evant genetic information are used; otherwise, transplantation procedures involving bone marrow, kidney or liver could be considered a form of gene therapy. The con cept of transfer of genetic information as a practical clinical tool arose from the gene-cloning technology, developed during the 1970s. Without the ability to isolate and replicate defined genetic sequences, it would be impossible to produce purified material for clinical use. The drive for the practical application of this technology came from the biotechnology industry with its quest for complex human biomole cules produced by recombinant techniques in bacteria. Within a decade, pharma ceutical-grade insulin, interferon, interleukin 2 and tumour necrosis factor were all involved in clinical trials. The next step was to obtain gene expression in vivo. Soft cover.
K. Sikora Gene therapy is one of the fastest developing areas in modern medical research. Transcending the classical preclinical and clinical disciplines, it is likely to have far reaching consequences in the practice of medicine, as we enter the next millennium. Currently, there are over 200 seperate active clinical trials with over 2,500 patients entered. These studies involve over 20 countries and include patients with a wide range of diseases, including cancer, HIV infection; cystic fibrosis (CF), haemophilia, diabetes, immune deficiencies, metabolic disorders, ischaemic heart disease and arthritis. Gene therapy can be defined as the deliberate transfer of DNA for therapeutic purposes. There is a further implication that only specific sequences containing rel evant genetic information are used; otherwise, transplantation procedures involving bone marrow, kidney or liver could be considered a form of gene therapy. The con cept of transfer of genetic information as a practical clinical tool arose from the gene-cloning technology, developed during the 1970s. Without the ability to isolate and replicate defined genetic sequences, it would be impossible to produce purified material for clinical use. The drive for the practical application of this technology came from the biotechnology industry with its quest for complex human biomole cules produced by recombinant techniques in bacteria. Within a decade, pharma ceutical-grade insulin, interferon, interleukin 2 and tumour necrosis factor were all involved in clinical trials. The next step was to obtain gene expression in vivo. Soft cover.
2
Symbolbild
Gene Therapy: Principles and Applications (Softcover reprint of the original 1st ed. 1999)
DE PB NWISBN: 9783034870139 bzw. 3034870132, in Deutsch, Springer Basel, Taschenbuch, neu.
Von Händler/Antiquariat, THE SAINT BOOKSTORE [51194787], Southport, United Kingdom.
BRAND NEW PRINT ON DEMAND., Gene Therapy: Principles and Applications (Softcover reprint of the original 1st ed. 1999), Thomas Blankenstein, K. Sikora Gene therapy is one of the fastest developing areas in modern medical research. Transcending the classical preclinical and clinical disciplines, it is likely to have far- reaching consequences in the practice of medicine, as we enter the next millennium. Currently, there are over 200 seperate active clinical trials with over 2,500 patients entered. These studies involve over 20 countries and include patients with a wide range of diseases, including cancer, HIV infection; cystic fibrosis (CF), haemophilia, diabetes, immune deficiencies, metabolic disorders, ischaemic heart disease and arthritis. Gene therapy can be defined as the deliberate transfer of DNA for therapeutic purposes. There is a further implication that only specific sequences containing rel- evant genetic information are used; otherwise, transplantation procedures involving bone marrow, kidney or liver could be considered a form of gene therapy. The con- cept of transfer of genetic information as a practical clinical tool arose from the gene-cloning technology, developed during the 1970s. Without the ability to isolate and replicate defined genetic sequences, it would be impossible to produce purified material for clinical use. The drive for the practical application of this technology came from the biotechnology industry with its quest for complex human biomole- cules produced by recombinant techniques in bacteria. Within a decade, pharma- ceutical-grade insulin, interferon, interleukin 2 and tumour necrosis factor were all involved in clinical trials. The next step was to obtain gene expression in vivo.
BRAND NEW PRINT ON DEMAND., Gene Therapy: Principles and Applications (Softcover reprint of the original 1st ed. 1999), Thomas Blankenstein, K. Sikora Gene therapy is one of the fastest developing areas in modern medical research. Transcending the classical preclinical and clinical disciplines, it is likely to have far- reaching consequences in the practice of medicine, as we enter the next millennium. Currently, there are over 200 seperate active clinical trials with over 2,500 patients entered. These studies involve over 20 countries and include patients with a wide range of diseases, including cancer, HIV infection; cystic fibrosis (CF), haemophilia, diabetes, immune deficiencies, metabolic disorders, ischaemic heart disease and arthritis. Gene therapy can be defined as the deliberate transfer of DNA for therapeutic purposes. There is a further implication that only specific sequences containing rel- evant genetic information are used; otherwise, transplantation procedures involving bone marrow, kidney or liver could be considered a form of gene therapy. The con- cept of transfer of genetic information as a practical clinical tool arose from the gene-cloning technology, developed during the 1970s. Without the ability to isolate and replicate defined genetic sequences, it would be impossible to produce purified material for clinical use. The drive for the practical application of this technology came from the biotechnology industry with its quest for complex human biomole- cules produced by recombinant techniques in bacteria. Within a decade, pharma- ceutical-grade insulin, interferon, interleukin 2 and tumour necrosis factor were all involved in clinical trials. The next step was to obtain gene expression in vivo.
3
Gene Therapy: Principles and Applications Blankenstein Editor
~EN PB NWISBN: 9783034870139 bzw. 3034870132, vermutlich in Englisch, Birkhï¿Â½user Basel, Taschenbuch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd, zzgl. Versandkosten.
K. Sikora Gene therapy is one of the fastest developing areas in modern medical research. Transcending the classical preclinical and clinical disciplines, it is likely to have far reaching consequences in the practice of medicine, as we enter the next millennium. Currently, there are over 200 seperate active clinical trials with over 2,500 patients entered. These studies involve over 20 countries and include patients with a wide range of diseases, including cancer, HIV infection; cystic fibrosis (CF), haemophilia, diabetes, immune deficiencies, metabolic disorders, ischaemic heart disease and arthritis. Gene therapy can be defined as the deliberate transfer of DNA for therapeutic purposes. There is a further implication that only specific sequences containing rel evant genetic information are used; otherwise, transplantation procedures involving bone marrow, kidney or liver could be considered a form of gene therapy. The con cept of transfer of genetic information as a practical clinical tool arose from the gene-cloning technology, developed during the 1970s. Without the ability to isolate and replicate defined genetic sequences, it would be impossible to produce purified material for clinical use. The drive for the practical application of this technology came from the biotechnology industry with its quest for complex human biomole cules produced by recombinant techniques in bacteria. Within a decade, pharma ceutical-grade insulin, interferon, interleukin 2 and tumour necrosis factor were all involved in clinical trials. The next step was to obtain gene expression in vivo.
K. Sikora Gene therapy is one of the fastest developing areas in modern medical research. Transcending the classical preclinical and clinical disciplines, it is likely to have far reaching consequences in the practice of medicine, as we enter the next millennium. Currently, there are over 200 seperate active clinical trials with over 2,500 patients entered. These studies involve over 20 countries and include patients with a wide range of diseases, including cancer, HIV infection; cystic fibrosis (CF), haemophilia, diabetes, immune deficiencies, metabolic disorders, ischaemic heart disease and arthritis. Gene therapy can be defined as the deliberate transfer of DNA for therapeutic purposes. There is a further implication that only specific sequences containing rel evant genetic information are used; otherwise, transplantation procedures involving bone marrow, kidney or liver could be considered a form of gene therapy. The con cept of transfer of genetic information as a practical clinical tool arose from the gene-cloning technology, developed during the 1970s. Without the ability to isolate and replicate defined genetic sequences, it would be impossible to produce purified material for clinical use. The drive for the practical application of this technology came from the biotechnology industry with its quest for complex human biomole cules produced by recombinant techniques in bacteria. Within a decade, pharma ceutical-grade insulin, interferon, interleukin 2 and tumour necrosis factor were all involved in clinical trials. The next step was to obtain gene expression in vivo.
4
Symbolbild
Gene Therapy: Principles and Applications (1998)
EN HC NWISBN: 9780817659721 bzw. 0817659722, in Englisch, 379 Seiten, Birkhauser, gebundenes Buch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, Usually ships in 2 to 4 weeks.
Von Händler/Antiquariat, Amazon.com.
K. Sikora Gene therapy is one of the fastest developing areas in modern medical research. Transcending the classical preclinical and clinical disciplines, it is likely to have far reaching consequences in the practice of medicine, as we enter the next millennium. Currently, there are over 200 seperate active clinical trials with over 2,500 patients entered. These studies involve over 20 countries and include patients with a wide range of diseases, including cancer, HIV infection; cystic fibrosis (CF), haemophilia, diabetes, immune deficiencies, metabolic disorders, ischaemic heart disease and arthritis. Gene therapy can be defined as the deliberate transfer of DNA for therapeutic purposes. There is a further implication that only specific sequences containing rel evant genetic information are used; otherwise, transplantation procedures involving bone marrow, kidney or liver could be considered a form of gene therapy. The con cept of transfer of genetic information as a practical clinical tool arose from the gene-cloning technology, developed during the 1970s. Without the ability to isolate and replicate defined genetic sequences, it would be impossible to produce purified material for clinical use. The drive for the practical application of this technology came from the biotechnology industry with its quest for complex human biomole cules produced by recombinant techniques in bacteria. Within a decade, pharma ceutical-grade insulin, interferon, interleukin 2 and tumour necrosis factor were all involved in clinical trials. The next step was to obtain gene expression in vivo. Hardcover, Label: Birkhauser, Birkhauser, Produktgruppe: Book, Publiziert: 1998-12, Studio: Birkhauser, Verkaufsrang: 17778580.
Von Händler/Antiquariat, Amazon.com.
K. Sikora Gene therapy is one of the fastest developing areas in modern medical research. Transcending the classical preclinical and clinical disciplines, it is likely to have far reaching consequences in the practice of medicine, as we enter the next millennium. Currently, there are over 200 seperate active clinical trials with over 2,500 patients entered. These studies involve over 20 countries and include patients with a wide range of diseases, including cancer, HIV infection; cystic fibrosis (CF), haemophilia, diabetes, immune deficiencies, metabolic disorders, ischaemic heart disease and arthritis. Gene therapy can be defined as the deliberate transfer of DNA for therapeutic purposes. There is a further implication that only specific sequences containing rel evant genetic information are used; otherwise, transplantation procedures involving bone marrow, kidney or liver could be considered a form of gene therapy. The con cept of transfer of genetic information as a practical clinical tool arose from the gene-cloning technology, developed during the 1970s. Without the ability to isolate and replicate defined genetic sequences, it would be impossible to produce purified material for clinical use. The drive for the practical application of this technology came from the biotechnology industry with its quest for complex human biomole cules produced by recombinant techniques in bacteria. Within a decade, pharma ceutical-grade insulin, interferon, interleukin 2 and tumour necrosis factor were all involved in clinical trials. The next step was to obtain gene expression in vivo. Hardcover, Label: Birkhauser, Birkhauser, Produktgruppe: Book, Publiziert: 1998-12, Studio: Birkhauser, Verkaufsrang: 17778580.
5
Gene Therapy: Principles and Applications (2003)
EN HC US FEISBN: 9783764359720 bzw. 3764359722, in Englisch, 380 Seiten, Birkhäuser, gebundenes Buch, gebraucht, Erstausgabe.
Neu ab: $79.83 (4 Angebote)
Gebraucht ab: $8.44 (9 Angebote)
Zu den weiteren 13 Angeboten bei Amazon.com
Lieferung aus: Vereinigte Staaten von Amerika, Usually ships in 1-2 business days.
Von Händler/Antiquariat, hippo_books.
K. Sikora Gene therapy is one of the fastest developing areas in modern medical research. Transcending the classical preclinical and clinical disciplines, it is likely to have far reaching consequences in the practice of medicine, as we enter the next millennium. Currently, there are over 200 seperate active clinical trials with over 2,500 patients entered. These studies involve over 20 countries and include patients with a wide range of diseases, including cancer, HIV infection; cystic fibrosis (CF), haemophilia, diabetes, immune deficiencies, metabolic disorders, ischaemic heart disease and arthritis. Gene therapy can be defined as the deliberate transfer of DNA for therapeutic purposes. There is a further implication that only specific sequences containing rel evant genetic information are used; otherwise, transplantation procedures involving bone marrow, kidney or liver could be considered a form of gene therapy. The con cept of transfer of genetic information as a practical clinical tool arose from the gene-cloning technology, developed during the 1970s. Without the ability to isolate and replicate defined genetic sequences, it would be impossible to produce purified material for clinical use. The drive for the practical application of this technology came from the biotechnology industry with its quest for complex human biomole cules produced by recombinant techniques in bacteria. Within a decade, pharma ceutical-grade insulin, interferon, interleukin 2 and tumour necrosis factor were all involved in clinical trials. The next step was to obtain gene expression in vivo. Hardcover, Ausgabe: 1, Label: Birkhäuser, Birkhäuser, Produktgruppe: Book, Publiziert: 2003-05-13, Studio: Birkhäuser, Verkaufsrang: 17750267.
Von Händler/Antiquariat, hippo_books.
K. Sikora Gene therapy is one of the fastest developing areas in modern medical research. Transcending the classical preclinical and clinical disciplines, it is likely to have far reaching consequences in the practice of medicine, as we enter the next millennium. Currently, there are over 200 seperate active clinical trials with over 2,500 patients entered. These studies involve over 20 countries and include patients with a wide range of diseases, including cancer, HIV infection; cystic fibrosis (CF), haemophilia, diabetes, immune deficiencies, metabolic disorders, ischaemic heart disease and arthritis. Gene therapy can be defined as the deliberate transfer of DNA for therapeutic purposes. There is a further implication that only specific sequences containing rel evant genetic information are used; otherwise, transplantation procedures involving bone marrow, kidney or liver could be considered a form of gene therapy. The con cept of transfer of genetic information as a practical clinical tool arose from the gene-cloning technology, developed during the 1970s. Without the ability to isolate and replicate defined genetic sequences, it would be impossible to produce purified material for clinical use. The drive for the practical application of this technology came from the biotechnology industry with its quest for complex human biomole cules produced by recombinant techniques in bacteria. Within a decade, pharma ceutical-grade insulin, interferon, interleukin 2 and tumour necrosis factor were all involved in clinical trials. The next step was to obtain gene expression in vivo. Hardcover, Ausgabe: 1, Label: Birkhäuser, Birkhäuser, Produktgruppe: Book, Publiziert: 2003-05-13, Studio: Birkhäuser, Verkaufsrang: 17750267.
6
Gene therapy : principles and applications. ed. by (1999)
DE USISBN: 9783764359720 bzw. 3764359722, in Deutsch, Basel , Boston , Berlin : Birkhäuser, gebraucht.
Von Händler/Antiquariat, Mosakowski & Stiasny GbR, [3737242].
XII, 379 S. : Ill., graph. Darst. , 24 cm Pp. Sofort verfügbar / Versand am folgenden Arbeitstag / mit Rechnung / daily shipping wordwide with invoice / ex library / / Sofort verfügbar / Rechnung mit ausgewiesener MwSt. liegt bei / daily shipping worldwide with invoice /, gebraucht sehr gut, 550g.
XII, 379 S. : Ill., graph. Darst. , 24 cm Pp. Sofort verfügbar / Versand am folgenden Arbeitstag / mit Rechnung / daily shipping wordwide with invoice / ex library / / Sofort verfügbar / Rechnung mit ausgewiesener MwSt. liegt bei / daily shipping worldwide with invoice /, gebraucht sehr gut, 550g.
7
Symbolbild
Gene therapy : principles and applications. ed. by (1999)
DEISBN: 3764359722 bzw. 9783764359720, in Deutsch, Basel , Boston , Berlin : Birkhäuser.
Lieferung aus: Deutschland, zzgl. Versandkosten.
Von Händler/Antiquariat, Mosakowski & Stiasny GbR, 61197 Florstadt.
XII, 379 S. : Ill., graph. Darst. , 24 cm Pp. Sofort verfügbar / Versand am folgenden Arbeitstag / mit Rechnung / daily shipping wordwide with invoice / ex library / Versand D: 2,90 EUR Gentherapie.
Von Händler/Antiquariat, Mosakowski & Stiasny GbR, 61197 Florstadt.
XII, 379 S. : Ill., graph. Darst. , 24 cm Pp. Sofort verfügbar / Versand am folgenden Arbeitstag / mit Rechnung / daily shipping wordwide with invoice / ex library / Versand D: 2,90 EUR Gentherapie.
8
Gene therapy : principles and applications. ed. by (1999)
~EN USISBN: 3764359722 bzw. 9783764359720, vermutlich in Englisch, Basel , Boston , Berlin : Birkhäuser, gebraucht.
Von Händler/Antiquariat, Mosakowski GbR, 61197 Florstadt.
Pp. XII, 379 S. : Ill., graph. Darst. , 24 cm Pappband Sofort verfügbar / Versand am folgenden Arbeitstag / mit Rechnung / daily shipping wordwide with invoice / ex library / Gentherapie, gebraucht; sehr gut, 2014-09-19.
Pp. XII, 379 S. : Ill., graph. Darst. , 24 cm Pappband Sofort verfügbar / Versand am folgenden Arbeitstag / mit Rechnung / daily shipping wordwide with invoice / ex library / Gentherapie, gebraucht; sehr gut, 2014-09-19.
9
Symbolbild
Gene Therapy: Principles and Applications (2003)
DE HCISBN: 9783764359720 bzw. 3764359722, in Deutsch, Birkhäuser Basel, gebundenes Buch.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten.
Von Händler/Antiquariat, Ergodebooks.
Birkhäuser Basel, 2003-05-13. 1. Hardcover. Used:Good. Buy with confidence. Excellent Customer Service & Return policy. Ships Fast. 24*7 Customer Service.
Von Händler/Antiquariat, Ergodebooks.
Birkhäuser Basel, 2003-05-13. 1. Hardcover. Used:Good. Buy with confidence. Excellent Customer Service & Return policy. Ships Fast. 24*7 Customer Service.
10
Symbolbild
Gene Therapy: Principles and Applications (2003)
DE HC USISBN: 9783764359720 bzw. 3764359722, in Deutsch, Birkhäuser Basel, gebundenes Buch, gebraucht.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten.
Von Händler/Antiquariat, Ergodebooks.
Birkhäuser Basel, 2003-05-13. Hardcover. Very Good. Buy with confidence. Excellent Customer Service & Return policy. Ships Fast. 24*7 Customer Service.
Von Händler/Antiquariat, Ergodebooks.
Birkhäuser Basel, 2003-05-13. Hardcover. Very Good. Buy with confidence. Excellent Customer Service & Return policy. Ships Fast. 24*7 Customer Service.
Lade…